Biotalys, founded in 2013, is a prominent player in the Agriculture, Biotechnology, and AgriTech industries, known for its pioneering work in precision biocontrols. With headquarters in Belgium, specifically within the biotech cluster in Ghent, the company utilizes its innovative AGROBODY™ technology platform to develop biocontrol solutions that combine the effectiveness of chemicals with the sustainability of biological methods.
Biotalys addresses key agricultural challenges by offering a diverse pipeline of protein-based solutions that enhance crop protection from soil to plate. The company, a spin-off from the VIB (Flanders Institute for Biotechnology), is publicly traded on Euronext Brussels.
Their most recent financing activity involved a Post-IPO Equity investment on 14 October 2024, though investor details were not disclosed. Biotalys' focus on environmental sustainability and agricultural innovation positions it as a compelling target for investors seeking impactful opportunities in the agri-biotechnology space.